150
Participants
Start Date
January 19, 2024
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
Nicotine nasal spray 0.5 mg
Participants will be administered nicotine nasal spray and provide subjective reactions
Placebo
Participants will be administered placebo nasal spray and provide subjective reactions
RECRUITING
Duke University Medical Center, Durham
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
Duke University
OTHER